Moreover, LILRB2 expression was significantly elevated in the CD1c+ mDC subpopulation within tumor tissues, particularly in poorly differentiated tumors, suggesting its potential role in suppressing immune responses 315, 316. This evidence concerns the gene LILRB2 and neoplasm.